Language:
KNOWLEDGE & RESOURCES
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Lexology Panoramic Mexico – Healthcare, Enforcement & Litigation 2026.
Authors: Armando Arenas & Karla Olvera
Healthcare funding. In general terms, how is healthcare, including access to medicines and medical devices, funded in your jurisdiction? Outline the roles of the public and private sectors.
Jan-07-2026 -
Lexology Panoramic – Healthcare Regulation 2026
Authors: Alejandro Luna F. & Luz Elena Elias
Dec-02-2025 -
Mexico Business – Infringement of Pharma Process Patents, Recent Mexico Precedents
Author: Armando Arenas
Jun-11-2025 - Mexico’s New Healthcare Procurement Model: Promise or Pitfall?Author: Ingrid Ortiz Ingrid Ortiz, a senior associate at OLIVARES law firm, examines one of the most significant medicine procurement transformations in Mexico’s history. Mar-31-2025
- Panoramic Mexico – Healthcare regulation 2025.Authors: Alejandro Luna F. & Luz Elena Elias Organisation, Financing and Structure of the Healthcare System. Mar-11-2025
- Mexico’s New Healthcare Procurement Model: Promise or Pitfall? Author: Alejandro Luna F.Mar-06-2025
- The Protection of Clinical Data in Mexico Still a Pending Issue. Author: Alejandro Luna F.Mar-04-2025
- Mexico Business – New Decree on Drug, Devices Importation Falls Short, Again. Author: Armando ArenasFeb-11-2025
- Lexology Panoramic: Healthcare Enforcement & Litigation 2025. Authors: Armando Arenas & Karla Olvera Dec-13-2024
- Mexico Business – Court Decision on Judicial Reform to Have Wide Impact.Author:Alejandro Luna F. Dec-05-2024
- Lexology Panoramic: Pharma & Medical Device Regulation 2025 – Mexico.Authors:Alejandro Luna F. & Ingrid Ortiz Udentify the competent authorities for approval of the marketing of medicinal products and medical devices. Nov-20-2024
- The Right (Legal Standing) To Claim Nullity of a Pharma Patent.Author:Armando Arenas Nov-01-2024
- Chambers Latín América 2024- Mexico: Life Science.Authors: Alejandro Luna F. & Luz Elena Elias Consequences of a Lack of a Proper Linkage System in Mexico Aug-29-2024
- Legal 500 Country Comparative Guides 2024 Authors: Alejandro Luna F, Ingrid Ortiz, Alexis Damian & Juan E. Figueroa Aug-14-2024
- ICLG – Pharmaceutical Advertising 2024. Authors: Ingrid Ortiz & Luz Elena Elías Aug-08-2024
- Mexico: regulatory certainty for biosimilars on the horizon. Authors: Alejandro Luna F. & Ingrid OrtizThe Guide to Life Sciences: Key issues for senior life sciences executives Jul-16-2024
- The Pharma Legal Handbook: Mexico 2023. Authors: Alejandro Luna F. & Ingrid OrtizThe Pharma Legal Handbook answers essential questions about this environment for pharmaceuticals in Mexico. It is a must have for any company operating in the country or looking to enter the market. Feb-14-2024
- Life Sciences Commercialisation in Mexico: Overview. Authors: Alejandro Luna F., Armando Arenas & Karla P. Olvera A Q&A guide to life sciences commercialisation in Mexico. Nov-29-2023
- Life Sciences Regulation in Mexico: Overview. Authors: Alejandro Luna F., Armando Arenas & Karla P. Olvera A Q&A guide to life sciences regulation in Mexico. Nov-29-2023
- Lexology GTDT – Pharma & Medical Device Regulation 2024 – Mexico. Authors: Ingrid Ortiz & Jorge Juarez Oct-27-2023
- Mexico’s patent linkage system and allopathic medicines. Authors: Alejandro Luna F. & Ingrid Ortiz Oct-13-2023
- Lexology GTDT Healthcare Regulation 2024 – Mexico.
Authors: Alejandro Luna F., y Luz Elena Elias.Sep-28-2023 - Lexology GTDT Healthcare Enforcement & Litigation 2023 – Mexico.
Authors: Alejandro Luna F., Armando Arenas & Karla Olvera.Aug-31-2023 - ICLG – Pharmaceutical Advertising 2023.
Authors: Ingrid Ortíz & Luz Elena Elías.Jul-14-2022 - Issues with the patent linkage system in Mexico.
Jul- 11 -2022 - Measures Needed to Counter Entry of Unauthorized Medicines.
Author: Armando Arenas.May- 25 -2022 - Lexology GTDT – Life Sciences 2023 – Mexico
Authors: Alejandro Luna F. & Ingrid OrtizDec- 13 -2022 - Lexology GTDT – Pharmaceutical Trademarks (WTR) 2023 – Mexico
Authors: Abraham Díaz & Karla OlveraDec- 08 -2022 - An Academic View of Compulsory Licenses and Alternatives
Authors: Alejandro Luna F. & Moises CastorenaDec- 07 -2022 - Lexology GTDT – Pharma & Medical Device Regulation 2023 – Mexico
Authors: Ingrid Ortiz & Luz Elena ElíasNov- 06 -2022 - The Pharma Legal Handbook Mexico – 2022.
Authors: Alejandro Luna F. & Ingrid OrtizAug- 31 -2022 - Lexology GTDT Healthcare Enforcement & Litigation 2023.
Authors: Alejandro Luna F., Armando Arenas & Karla OlveraAug- 26 -2022 - IAM Life Sciences 2022 – Legal and strategic questions surrounding biologic and biosimilar litigation.
Authors: Karla Olvera & Ingrid OrtízAug- 25 -2022 - Patent Term Compensation for the Life Sciences.
Authors: Alejandro Luna F.Jul- 29 -2022 - ICLG Pharmaceutical Advertising 2022 – Mexico.
Authors: Alejandro Luna F. & Armando ArenasMay- 25 -2022 - ICLG Digital Health 2022 – Mexico.
F- 03 -2022 - Answers essential questions about this environment for pharmaceuticals in Mexico.
Authors: Alejandro Luna F. & Ingrid Ortíz
The Pharma Legal Handbook answers essential questions about the environment for pharmaceuticals in Mexico. It is a must have for any company operating in the country or looking to enter the market.
Jan- 18 -2022 - Patent waiving Is not the solution to enhance access.
Jan- 17 -2022 - Health & Patent Rights During the COVID-19 Pandemic.
Jan- 05 -2022 - Lexology GTDT – Pharma & Medical Device Regulation 2022 – Mexico.
Jan- 03 -2022 - Lexology GTDT – Life Sciences 2022 – Mexico.
Jan- 03 -2022 - Lexology GTDT Healthcare Enforcement & Litigation 2022 – Mexico.
Jul- 05 -2021 - Health & Patent Rights During the COVID-19 Pandemic.
Jul- 05 -2021 - Commercialisation of Healthcare in Mexico: Overview.
Jun- 29 -2021 - ICLG – Pharmaceutical Advertising 2021.
Jun- 29 -2021 - Pharma Board Room – Legal & Regulatory – Mexico – Health & Patent Rights During the COVID-19 Pandemic.
Jun- 11 -2021 - Pharmaceutical IP and competition law in Mexico: overview.
Jun- 01 -2021 - Medicinal producto regulation and producto liability in Mexico: overview.
Jun- 01 -2021 - Life Sciences Global Guide Mexico – Pharmaceutilcal IP and competition law in Mexico: overview.
May- 13 -2021 - Life Sciences Global Guide Mexico – Medicinal product regulation and product liability en Mexico: overvew.
May- 13 -2021 - Mexico Business.news Health Do New Medicine Procurement Rules Violate Constitution?
Apr- 13 -2021 - ICLG – Digital Health 2021: Digital Health and Health Care IT
Mar- 05 -2021 - A debated shortcut for import permits of foreign pharmaceutical products in Mexico
Mar- 05 -2021 - Lexology GTDT Healthcare Enforcement & Litigation 2021 – MexicoJan -06-2021
- Lexology GTDT – Life Sciences 2021 – MexicoJan -06-2021
- Lexology GTDT Agribusiness 2021 – MexicoJan -06-2021
- Lexology GTDT – Pharmaceutical Trademarks 2021 – MexicoDic -17-2020
- A debated shortcut for import permits of foreign pharmaceutical products in Mexico
Dec- 02 -2020 - Lexology GTDT – Pharma & Medical Device Regulation 2021 – Mexico
Oct- 12 -2020 - Second-Use Patents and the New Mexican IP Law
Sep- 23 -2020 - USMCA Entry Demands Amendments to Mexican Regulations
Ago- 18 -2020 - ICLG Pharmaceutical Advertising 2020
Jun -08 -2020 - Regulatory framework-healthcare products and Intellectual Property in Mexico. IAM 2020
May -29 -2020 - The Life Sciences Lawyer. COVID-19: The invisible enemy revisited.
May -22 -2020 - Exceptional Measures for Exceptional Times.
May -12 -2020 - ICLG Digital Health 2020
Mar -11 -2020 - Lexology GTDT Pharma & Medical Device Regulation 2020
Feb -13 -2020 - Regulating cannabis use in Mexico – current legal framework
Dec -06 -2019 - Healt Services Framework And Competent Authorities
Nov -13 -2019 - Pharma & Medical Device Regulation 2020 – Mexico
Nov -11 -2019 - Pharmaceutical IP and competition law in Mexico: overview
Sep -03 -2019 - Medicinal product regulation and product liability in Mexico: overview
Sep -03 -2019 - Commercialisation of healthcare in Mexico: overview
Aug -29 -2019 - WTR Pharmaceutical Trademark Guide 2020
Aug -27 -2019 - 2020 Edition of Healthcare Enforcement & Litigation Mexico
Aug -06 -2019 - ICLG Pharmaceutical Advertising 2019
Jul -09 -2019 - ICLG Pharmaceutical Advertising 2019
Jun -21 -2019 - GTDT Healthcare Enforcement & Litigation 2019
Nov -20 -2018 - IAM Life Sciences
May -31 -2018 - The International Comparative Legal Guide to Pharmaceutical Advertising 2018 Edition – Mexico
May – 15 – 2018 - Product regulation and liability in Mexico
Apr – 18 – 2018 - Impact of the “Comprehensive and Progressive Agreement for Trans-Pacific Partnership” on Life Sciences in Mexico
Mar – 28 – 2018 - Pharmaceutical Trademarks: A Global Guide 2018/2019
Mar – 27 -2018 - Mexico Commercialisation of Healthcare
Feb – 20 2018 - Life Sciences IP Review Bio 2017 edition
Jan – 25 -2018 - Practical Law’s Commercialisation of Healthcare Global Guide
Jan – 25 -2018 - Pharma 2018-2019
Jan – 2018 - Getting the Deal Through – Life Sciences
Jan – 2018 - Legal Q&A – Pharma Boardroom
Jan – 2018 - Pharmaceutical IP and competition law in Mexico: overview
Aug-16-2017 - IP rights protection and enforcement strategies for plant innovations in Mexico
Aug-15-2017 - Commercialisation of Healthcare in Mexico: Overview
Aug-15-2017 - Life Sciences – Product regulation and liability in Mexico
Jun-14-2017 - ICLG Pharmaceutical Advertising 2017
May-30-2017 - Medicinal product regulation and product liability in Mexico: overview May 2017
May-15-2017 - Pharma Boardroom Interview
Apr-03-2017 - Cannabis and Narcotics for Medicinal use in Mexico
Mar-08-2017 - ICLG to: Pharmaceutical Advertising 2016
Jun-22-2016 - Chapter 18 of TPP hits the Mexican life sciences industry
May-26-2016 - Medicinal product regulation and product liability in Mexico: overview
Mar-03-2016 - Chapter 18 of the TPP hits the life science industry in Mexico
Feb-11-2016 - Getting the Deal Through – Life Sciences 2016
Nov-03-2015 - Latest developments in biologics and biosimiliar regulation
Oct-23-2015 - Data protection exclusivity for biologics
Oct-08-2015 - ICLG Pharma Advertising 2015
Jun-22-2015 - Tightening the Customs Net
Jun-22-2015 - Key issues for biotech products in mexico
Jun-08-2015 - Pharmaceutical Law and Intellectual Property in Latin America
Apr-06-2015 - Pharmaceutical Trademark Guide – Mexico 2015
Feb-17-2015 - Getting the Deal Through – Life Science 2015
Feb-17-2015 - Life Sciences – Multi-jurisdictional Guide 2013: Mexico
Feb-17-2015 - Life Sciences – Multi-jurisdictional Guide 2014: Mexico
Feb-17-2015 - Getting the Deal Through – Life Sciences 2014
Aug-25-2014 - APIs, imports and the Bolar exemption: concerns and practical measures
Feb-04-2014 - Current Conditions of Use Claims in the Pharmaceutical Sector in Mexico
Apr-01-2013 - Crossed wires: protecting medicines in Mexico
Apr-01-2013 - Life Sciences – Multi-jurisdictional Guide 2012: Mexico
Jun-20-2012 - Maximising IP rights in the life sciences industry
Jun-08-2012 - Latin America Roundtable
Sep-13-2011 - New regulations pending
Sep-12-2011 - The International Comparative Legal Guide to: Patents 2012
Sep-06-2011 - Approval of follow-on biologics in Mexico
Jun-02-2011 - Global Pharmaceutical Linkage Regulations: A Proposed Analytical Framework
May-04-2011 - Life Sciences Handbook 2011 – Country Q&A
Mar-25-2011 - Supreme Court upholds the worth of formulation patents
Jul-27-2010 - Pharmaceutical Trademarks 2009
Jun-11-2010 - Pharmaceutical Advertising 2008
Jun-11-2010 - Framework for biotherapeutic products established
Jun-09-2010 - Repercussions expected on medicine advertising campaign in Mexico
May-28-2010 - Drugs Patent Reforms Introduced
Apr-01-2004